Actively Recruiting

Phase Not Applicable
Age: 18Years - 44Years
FEMALE
NCT06982677

Improving Outcomes in Early Menopause After Cancer

Led by Duke University · Updated on 2026-05-14

117

Participants Needed

1

Research Sites

66 weeks

Total Duration

On this page

Sponsors

D

Duke University

Lead Sponsor

N

National Cancer Institute (NCI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this study is to create and test a new program led by nurse navigators to help women who experience early menopause after cancer. The program includes personalized menopause education, decision support, and skills to manage menopause symptoms. The main questions it aims to answer are: 1. Is the program easy to join, engaging, and well-received by participants? 2. Does the program group show greater improvements in knowledge, decision-making, confidence, and menopause symptom management compared to the control group? Participants will complete sessions of either the program being tested or an educational control program with a nurse navigator via video. Participants will also complete questionnaires when they start the study and again about 10 weeks later.

CONDITIONS

Official Title

Improving Outcomes in Early Menopause After Cancer

Who Can Participate

Age: 18Years - 44Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Female (biological sex)
  • Age 18 to 44 years old
  • Completed cancer treatment (other than endocrine therapy) more than 12 months prior to enrollment
  • Have not had a menstrual period for more than 12 months (amenorrhea)
  • Able to speak and read English
Not Eligible

You will not qualify if you...

  • Diagnosis of metastatic cancer
  • Visual or hearing impairment that would interfere with participation
  • Cognitive impairment or severe mental illness that would interfere with participation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Duke Cancer Institute

Durham, North Carolina, United States, 27705

Actively Recruiting

Loading map...

Research Team

S

Smrithi Divakaran, MPH

CONTACT

M

Michael W Willis

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here